Microbiological insights into respiratory infections and the opportunities for inhaled therapy

Full text not archived in this repository.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Bruce, K.D., Rogers, G.B. and Patel, N. orcid id iconORCID: https://orcid.org/0000-0002-8600-0663 (2011) Microbiological insights into respiratory infections and the opportunities for inhaled therapy. Journal of Drug Delivery Science and Technology, 21 (4). pp. 301-309. ISSN 1773-2247

Abstract/Summary

Respiratory infections represent the fourth most common cause of all deaths across age groups and countries. Treating these infections appropriately is a clear clinical priority and here we outline the types of therapy that are in current use for some of these infections. It is important that treatments are further improved and the potential of inhaled delivery to fulfil this need is considered. We describe novel methodologies that are being applied for the identification and enumeration of microorganisms in the respiratory tract, and propose that ways of improving therapy may arise from understanding better the etiology of respiratory infection and the impact of inhaled drug therapies. The potential for translational benefits for patients are also discussed.

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/37514
Refereed Yes
Divisions No Reading authors. Back catalogue items
Publisher Editions de Sante
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar